Condition
Triple-Negative Breast Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Triple-Negative Breast Carcinoma clinical trials that are recruiting, in United States. By phase: Phase 2 (2), Phase 1/2 (1), Phase 1 (1). The most active sponsors are Ohio State University Comprehensive Cancer Center (2), Mayo Clinic (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 1Country
Newest Triple-Negative Breast Carcinoma clinical trials
All recruiting trials (10)
-
Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression
This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.
-
Darolutamide alone or with standard pre-surgery therapy for stage II–IIIA AR‑positive triple‑negative breast cancer.
This trial will test whether adding darolutamide to standard pre-surgery chemo‑immunotherapy helps people with stage II–IIIA androgen receptor–positive triple‑negative breast cancer.
-
Hypofractionated radiotherapy for non-metastatic breast cancer treatment
This study is testing if giving a shorter course of radiation therapy before or after surgery can help women with non-metastatic breast cancer while causing fewer severe side effects.
-
Nutrition intervention for women with triple negative breast cancer
This study is testing if following a healthy eating plan called the MIND diet can help women with triple negative breast cancer feel better mentally and physically while they are undergoing chemotherapy.
-
Improving access to genetic testing for underserved cancer patients
This study is testing whether a computer character can give better information about genetic testing to underserved cancer patients compared to regular human healthcare providers.
-
Biobehavioral stress reduction for patients with triple negative breast cancer
This study is testing a stress reduction program for people who have just been diagnosed with triple negative breast cancer to see if it helps them feel better and cope with their situation.
-
Personalized vaccine combined with pembrolizumab for advanced solid tumors
This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.
-
Combining ZEN003694 and Binimetinib for Advanced Solid Tumors with RAS Alterations
This study is testing a combination of two cancer drugs, ZEN003694 and binimetinib, to see if they can help people with advanced solid tumors that have RAS changes.
-
Caloric restriction combined with targeted radiation therapy for early stage breast cancer
This study is testing if cutting calories while getting targeted radiation therapy can help reduce tumor size more in people with early stage breast cancer compared to just the radiation alone.
-
Eliminating surgery and radiation for certain breast cancer patients
This study is testing if some breast cancer patients can skip surgery and just use radiation therapy after their initial treatment to see how it affects their cancer and quality of life.
Related topics
Quick answers
How many Triple-Negative Breast Carcinoma clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.